Document is current
Any future updates will be listed below
-
Authors
Liu, Ying https://orcid.org/0009-0002-6188-2580
Deng, Shaofeng
Ren, Shuang
Tam, Rachel Chun-Yee
Liu, Siwen
Zhang, Anna Jinxia https://orcid.org/0000-0002-5087-3614
To, Kelvin Kai-Wang https://orcid.org/0000-0002-1921-5824
Yuen, Kwok-Yung https://orcid.org/0000-0002-2083-1552
Chen, Honglin https://orcid.org/0000-0001-5108-8338
Wang, Pui https://orcid.org/0000-0003-0745-1130
-
Funding
Funding for this research was provided by:
Health@InnoHK Innovation and Technology Mission The Themes-Based Research Scheme, Hong Kong SAR
- License Information
-
More Information
Article History
Received: 22 August 2024
Accepted: 21 March 2025
First Online: 1 April 2025
Competing interests
: The authors declare that the University of Hong Kong owns patents on work related to the generation and application of DelNS1 live attenuated influenza vaccines and the associated platform, with H.C., P.W. and K-Y.Y. included as co-inventors. There is no restriction on the publication of data. The other authors declare that they have no competing interests.
